The FDA approves Allergan’s (AGN -1%)
Durysta (bimatoprost implant) 10 mcg for lowering intraocular pressure
in patients with open-angle glaucoma or ocular hypertension.
The biodegradable sustained-release implant is administered via intracameral (into the eye cavity) injection.
https://seekingalpha.com/news/3549041-fda-oks-allergan-eye-implant-for-glaucoma
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.